Lanreotide in the prevention and management of high-output ileostomy after colorectal cancer surgery

References

• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (Oxford, England: 1990). 2013;49:1374–1403.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) Rectal Cancer; 2016.
   Google Scholar
• National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) Colon Cancer; 2016.
   Google Scholar
• Labianca R, Nordlinger B, Beretta GD, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl.6):vi64–vi72.
   PubMed Web of Science ®Google Scholar
• Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006;107:2581–2588.
   PubMed Web of Science ®Google Scholar
• Schmoll HJ, Van Cutsem E, Stein A, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer: a personalized approach to clinical decision making. Ann Oncol. 2012;23:2479–2516.
   PubMed Web of Science ®Google Scholar
• Beets GL. Is a diverting stoma always necessary for a low anterior resection of a rectal cancer? In: Valentini V, Schmoll H-J, van de Velde CJH, editors. Multidisciplinary management of rectal cancer; Berlin Heidelberg: Springer-Verlag; 2012. p. 257–259.
   Google Scholar
• Hanna MH, Vinci A, Pigazzi A. Diverting ileostomy in colorectal surgery: when is it necessary? Langenbecks Arch Surg. 2015;400:145–152.
   PubMed Web of Science ®Google Scholar
• Montedori A, Cirocchi R, Farinella E, et al. Covering ileo- or colostomy in anterior resection for rectal carcinoma. Cochrane Database Syst Rev. 2010;12(5):CD006878.
   Google Scholar
• Guenaga KF, Lustosa SA, Saad SS, et al. Ileostomy or colostomy for temporary decompression of colorectal anastomosis. Cochrane Database Syst Rev. 2007;24(1):CD004647.
   Google Scholar
• Tilney HS, Sains PS, Lovegrove RE, et al. Comparison of outcomes following ileostomy versus colostomy for defunctioning colorectal anastomoses. World J Surg. 2007;31:1142–1151.
   PubMed Web of Science ®Google Scholar
• Debongnie JC, Phillips SF. Capacity of the human colon to absorb fluid. Gastroenterology. 1978;74:698–703.
   PubMed Web of Science ®Google Scholar
• Phillips SF, Giller J. The contribution of the colon to electrolyte and water conservation in man. J Lab Clin Med. 1973;81:733–746.
   PubMed Web of Science ®Google Scholar
• Baker ML, Williams RN, Nightingale JM. Causes and management of a high-output stoma. Colorect Dis. 2011;13:191–197.
   PubMed Web of Science ®Google Scholar
• Arenas Villafranca JJ, López-Rodríguez C, Abilés J, et al. Protocol for the detection and nutritional management of high-output stomas. Nutr J. 2015;14:45.
   PubMed Web of Science ®Google Scholar
• Kwiatt M, Kawata M. Avoidance and management of stomal complications. Clin Colon Rect Surg. 2013;26:112–121.
   PubMed Web of Science ®Google Scholar
• Chun LJ, Haigh PI, Tam MS, et al. Defunctioning loop ileostomy for pelvic anastomoses: predictors of morbidity and nonclosure. Dis Colon Rect. 2012;55:167–174.
   PubMed Web of Science ®Google Scholar
• Peter C, Neil H. Ostomy management. In: Yeo CJ, McFadden DW, Pemberton JH, et al. editors. Shackelford’s surgery of the alimentary tract. Philadelphia (PA): Elsevier Health Sciences; 2012. p. 2248–2261.
   Google Scholar
• Nightingale J, Woodward JM. Guidelines for management of patients with a short bowel. Gut. 2006;55:iv1–iv12.
   PubMed Web of Science ®Google Scholar
• Stein A, Voigt W, Jordan K. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol. 2010;2:51–63.
   PubMedGoogle Scholar
• Forbes A. Intestinal failure and short bowel syndrome. Medicine. 2003;31:98–100.
   Google Scholar
• Biagi JJ, Raphael MJ, Mackillop WJ, et al. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA. 2011;305:2335–2342.
   PubMed Web of Science ®Google Scholar
• Phatak UR, Kao LS, You YN, et al. The impact of ileostomy-related complications on the multidisciplinary treatment of rectal cancer. Ann Surg Oncol. 2014;21:507–512.
   PubMed Web of Science ®Google Scholar
• Nightingale JM, Kamm MA, van der Sijp JR, et al. Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake’. Gut. 1993;34:1171–1176.
   PubMed Web of Science ®Google Scholar
• Lundeen SJ, Otterson MF, Binion DG, et al. Clostridium difficile enteritis: an early postoperative complication in inflammatory bowel disease patients after colectomy. J Gastrointest Surg. 2007;11:138–142.
   PubMed Web of Science ®Google Scholar
• Bisschops R, De Ruyter V, Demolin G, et al. Lanreotide autogel in the treatment of idiopathic refractory diarrhea: results of an exploratory, controlled, before and after, open-label, multicenter, prospective clinical trial. Clin Ther. 2016;38:1902–1911 e1902.
   PubMed Web of Science ®Google Scholar
• Schoeters P, De Pooter K. Lanreotide autogel in the treatment of persistent diarrhea following a total colectomy. Case Rep Gastrointest Med. 2015;2015:686120.
   PubMedGoogle Scholar
• Peeters M, Van den Brande J, Francque S. Diarrhea and the rationale to use Sandostatin. Acta Gastroenterol Belg. 2010;73:25–36.
   PubMed Web of Science ®Google Scholar
• Gayral F, Campion JP, Regimbeau JM, et al. Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae. Ann Surg. 2009;250:872–877.
   PubMed Web of Science ®Google Scholar
• Szilagyi A, Shrier I. Systematic review: the use of somatostatin or octreotide in refractory diarrhoea. Aliment Pharmacol Ther. 2001;15:1889–1897.
   PubMed Web of Science ®Google Scholar
• Nehra V, Camilleri M, Burton D, et al. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol. 2001;96:1494–1498.
   PubMed Web of Science ®Google Scholar
• Mulvihill SJ. Perioperative use of octreotide in gastrointestinal surgery. Digestion. 1993;54(Suppl.1):33–37.
   PubMed Web of Science ®Google Scholar
• Drewe J, Sieber CC, Mottet C, et al. Dose-dependent gastrointestinal effects of the somatostatin analog lanreotide in healthy volunteers. Clin Pharmacol Ther. 1999;65:413–419.
   PubMed Web of Science ®Google Scholar
• Lamrani A, Vidon N, Sogni P, et al. Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans. Br J Clin Pharmacol. 1997;43:65–70.
   PubMed Web of Science ®Google Scholar
• Sobhani I, Rene E, Ramdani A, et al. Lanreotide inhibits human jejunal secretion induced by prostaglandin E1 in healthy volunteers. Br J Clin Pharmacol. 1996;41:109–114.
   PubMed Web of Science ®Google Scholar
• Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut. 1994;35:S1–S4.
   PubMed Web of Science ®Google Scholar
• Kusuhara K, Kusunoki M, Okamoto T, et al. Reduction of the effluent volume in high-output ileostomy patients by a somatostatin analogue, SMS 201-995. Int J Colorect Dis. 1992;7:202–205.
   PubMed Web of Science ®Google Scholar
• Ladefoged K, Christensen KC, Hegnhoj J, et al. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut. 1989;30:943–949.
   PubMed Web of Science ®Google Scholar
• Neef B, Horing E, von Gaisberg U. Successful treatment of a life-threatening ileostomy diarrhea with the somatostatin analog octreotide. Deutsche Med Wochenschrift (1946). 1994;119:869–874.
   PubMed Web of Science ®Google Scholar
• Nightingale JM, Walker ER, Burnham WR, et al. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther. 1989;3:367–373.
   PubMed Web of Science ®Google Scholar
• Shaffer JL, O’Hanrahan T, Rowntree S, et al. Does somatostatin analogue (201–995) reduce high output stoma effluent? A controlled trial. Gut. 1988;29:A1432–A1433.
   Web of Science ®Google Scholar
• Cooper JC, Williams NS, King RF, et al. Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea. Br J Surg. 1986;73:128–131.
   PubMed Web of Science ®Google Scholar